Key result
In patients with acute coronary syndrome, having both CRP and TnT in the top quartiles was associated with a 9.1% 30-day mortality rate, compared to 0.3% for those in the bottom quartiles.
Why the study?
Both CRP and TnT predict future coronary events in ACS, but the relationships between marker levels and the individual end points of mortality and MI remained unclear.
Cohort (n=7,108)
Yes
Absolute Event Rate: 9.1% vs 0.3%
No takes yet. Share an insight, caveat, or question.
Captured external expert commentary on this paper, strongest first. Original sources are linked where available.
“Biomarkers are analyzed in blood samples taken from patients when they are admitted to the hospital. With a better understanding of these markers, we will be able to assess risk for individual patients more accurately.”
“This is an important finding because in many centers across the world, if patients present with acute coronary syndromes, they are”
May aid post-ACS risk stratification with troponin and CRP; leaves open causal roles and therapeutic implications.
James et al. (2003) conducted a cohort in acute coronary syndrome (n=7,108). Baseline levels of C-reactive protein (CRP) and troponin T (TnT) vs. Bottom quartiles of CRP and TnT was evaluated on 30-day mortality. In patients with acute coronary syndrome, having both CRP and TnT in the top quartiles was associated with a 9.1% 30-day mortality rate, compared to 0.3% for those in the bottom quartiles.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: